IL-23 inhibitors may have a lower risk of paradoxical eczema in comparison to other biologics
1. Interleukin-23 inhibitors had a lower risk of developing paradoxical eczema when treated for plaque psoriasis compared to TNF inhibitors, ...
1. Interleukin-23 inhibitors had a lower risk of developing paradoxical eczema when treated for plaque psoriasis compared to TNF inhibitors, ...
1. Upadacitinib, a new once-daily oral systemic medication, reduces eczema severity and improves clinician- and patient-reported measures in adolescents with ...
1. Adulthood atopic dermatitis (AD) was significantly associated with an increased risk of venous thromboembolism (VTE); however, the absolute risk ...
1. Online mindfulness and self-compassion training, in addition to usual dermatologic care, improved the quality of life, disease symptoms, and ...
1. Interleukin-13 targeted treatment with tralokinumab was effective and well-tolerated for adolescent moderate-to-severe atopic dermatitis. 2. No new safety signals ...
1. In two phase three trials, 16 weeks of lebrikizumab treatment effectively treated adolescents and adults with moderate-to-severe atopic dermatitis. ...
1. In this longitudinal cohort study, infants who did not develop atopic disease consumed breast milk containing higher concentrations of ...
Probiotic Bi-07 is non-inferior to lactase supplementation in patients with lactose intolerance 1. In this randomized controlled trial, the probiotic ...
1. At week 16, all rocatinlimab groups reported significant improvements in eczema severity. 2. Most treatment-related adverse events were mild-to-moderate, ...
1. By week 16, 28% of patients in dupilumab reported clear or almost clear skin (IGA 0-1) compared to 4% ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.